KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Return on Sales (2018 - 2025)

ClearPoint Neuro's Return on Sales history spans 13 years, with the latest figure at 0.66% for Q3 2025.

  • For Q3 2025, Return on Sales fell 5.0% year-over-year to 0.66%; the TTM value through Sep 2025 reached 0.68%, down 8.0%, while the annual FY2024 figure was 0.63%, 31.0% up from the prior year.
  • Return on Sales for Q3 2025 was 0.66% at ClearPoint Neuro, down from 0.63% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.54% in Q1 2024 and bottomed at 1.2% in Q2 2023.
  • The 5-year median for Return on Sales is 0.74% (2022), against an average of 0.79%.
  • The largest annual shift saw Return on Sales plummeted -47bps in 2021 before it surged 64bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.97% in 2021, then rose by 11bps to 0.86% in 2022, then rose by 20bps to 0.69% in 2023, then fell by -5bps to 0.73% in 2024, then rose by 9bps to 0.66% in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Return on Sales are 0.66% (Q3 2025), 0.63% (Q2 2025), and 0.71% (Q1 2025).